Gregory Downey - 14 Oct 2022 Form 4/A - Amendment Insider Report for Lexaria Bioscience Corp. (LEXX)

Reporting relationship: Chief Financial Officer
Issuer ticker: LEXX
Reported as of: 14 Oct 2022
Net transaction value: +$253
SEC form: 4/A - Amendment
Accepted by SEC: 18 Oct 2022, 18:31:43 UTC
Original report date: 18 Oct 2022
Prior SEC filing: 29 Aug 2022
Source filing: View source filing
Reporting owner signature: /Gregory Downey/

Key filing fact

Gregory Downey filed Form 4/A - Amendment for Lexaria Bioscience Corp. (LEXX) on 18 Oct 2022.

Key facts

This page summarizes Gregory Downey's Form 4/A - Amendment filing for Lexaria Bioscience Corp. (LEXX).
1 reported transaction and 7 derivative rows are listed below.
Accepted by SEC: 18 Oct 2022, 18:31.

Change

Previous filing in this sequence was filed on 29 Aug 2022.
Current net transaction value: +$253.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LEXX transaction

common shares

Purchase

Transaction value: $253
Shares: +121
Change %: +6.6%
Price: $2.09
Shares after: 1,954
Date: 14 Oct 2022
Ownership: Direct
Footnotes: F1

LEXX holding

common shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,833
Date: 14 Oct 2022
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,000
Date: 14 Oct 2022
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 4,000
Exercise price: $5.04

LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 8,000
Date: 14 Oct 2022
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 4,000
Exercise price: $5.04

LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 12,000
Date: 14 Oct 2022
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 4,000
Exercise price: $5.04

LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 17,000
Date: 14 Oct 2022
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 5,000
Exercise price: $5.31

LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 25,000
Date: 14 Oct 2022
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 8,000
Exercise price: $7.08

LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 35,000
Date: 14 Oct 2022
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 10,000
Exercise price: $6.23

LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 46,000
Date: 14 Oct 2022
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 11,000
Exercise price: $2.91

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This Form 4A is being filed to correct the transaction code for the open market purchase made by Mr. Downey as originally notated as a grant or award in the Form 4 filed on October 18, 2022.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .